Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Urgent Surgical Treatment of Aortic Endocarditis in Infants and Children.

Amir G, Frenkel G, Rotstein A, Nachum E, Bruckheimer E, Lowenthal A, Einbinder T, Birk E.

Pediatr Cardiol. 2019 Mar;40(3):580-584. doi: 10.1007/s00246-018-2030-5. Epub 2019 Jan 2.

PMID:
30604277
2.

Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer.

Gerner EW, Bruckheimer E, Cohen A.

J Biol Chem. 2018 Nov 30;293(48):18770-18778. doi: 10.1074/jbc.TM118.003343. Epub 2018 Oct 24. Review.

PMID:
30355737
3.

Doxorubicin-Eluting Intra-Arterial Therapy for Pediatric Extra-Abdominal Desmoid Fibromatoses: A Promising Approach for a Perplexing Disease.

Elnekave E, Atar E, Amar S, Bruckheimer E, Knizhnik M, Yaniv I, Dujovny T, Feinmesser M, Ash S.

J Vasc Interv Radiol. 2018 Oct;29(10):1376-1382. doi: 10.1016/j.jvir.2018.04.009. Epub 2018 Jul 31.

PMID:
30075974
4.

Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.

Raghunand N, Scicinski J, Guntle GP, Jagadish B, Mash EA, Bruckheimer E, Oronsky B, Korn RL.

Oncotarget. 2017 Jun 12;8(60):102511-102520. doi: 10.18632/oncotarget.18455. eCollection 2017 Nov 24.

5.

Topical propranolol improves epistaxis in patients with hereditary hemorrhagic telangiectasia - a preliminary report.

Mei-Zahav M, Blau H, Bruckheimer E, Zur E, Goldschmidt N.

J Otolaryngol Head Neck Surg. 2017 Oct 4;46(1):58. doi: 10.1186/s40463-017-0235-x.

6.

Neonatal Cardiac Surgery in the New Era: Lessons learned from 1000 Consecutive Cases.

Amir G, Frenkel G, Bruckheimer E, Lowenthal A, Rotstein A, Katz J, Zeitlin Y, Schiller O, Birk E.

Isr Med Assoc J. 2016 Nov;18(11):645-648.

7.

Limited fluoroscopy catheter ablation of accessory pathways in children.

Swissa M, Birk E, Dagan T, Abby Naimer S, Fogelman M, Einbinder T, Bruckheimer E, Fogelman R.

J Cardiol. 2017 Oct;70(4):382-386. doi: 10.1016/j.jjcc.2016.12.018. Epub 2017 Mar 6.

8.

Radiofrequency catheter ablation of atrioventricular node reentrant tachycardia in children with limited fluoroscopy.

Swissa M, Birk E, Dagan T, Naimer SA, Fogelman M, Einbinder T, Bruckheimer E, Fogelman R.

Int J Cardiol. 2017 Jun 1;236:198-202. doi: 10.1016/j.ijcard.2017.01.128. Epub 2017 Jan 31.

PMID:
28202257
9.

Comparative mutational landscape analysis of patient-derived tumour xenografts.

Brait M, Izumchenko E, Kagohara LT, Long S, Wysocki PT, Faherty B, Fertig EJ, Khor TO, Bruckheimer E, Baia G, Ciznadija D, Sloma I, Ben-Zvi I, Paz K, Sidransky D.

Br J Cancer. 2017 Feb 14;116(4):515-523. doi: 10.1038/bjc.2016.450. Epub 2017 Jan 24.

10.

Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK).

Ott GR, Cheng M, Learn KS, Wagner J, Gingrich DE, Lisko JG, Curry M, Mesaros EF, Ghose AK, Quail MR, Wan W, Lu L, Dobrzanski P, Albom MS, Angeles TS, Wells-Knecht K, Huang Z, Aimone LD, Bruckheimer E, Anderson N, Friedman J, Fernandez SV, Ator MA, Ruggeri BA, Dorsey BD.

J Med Chem. 2016 Aug 25;59(16):7478-96. doi: 10.1021/acs.jmedchem.6b00487. Epub 2016 Aug 15.

PMID:
27527804
11.

Reply to Letter Regarding "Amplatzer Vascular Plugs Versus Coils for Embolization of Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia".

Tau N, Atar E, Mei-Zahav M, Bachar GN, Dagan T, Birk E, Bruckheimer E.

Cardiovasc Intervent Radiol. 2016 Oct;39(10):1520. doi: 10.1007/s00270-016-1448-5. Epub 2016 Aug 9. No abstract available.

PMID:
27506772
12.

Pulmonary hypertension specific treatment in infants with bronchopulmonary dysplasia.

Kadmon G, Schiller O, Dagan T, Bruckheimer E, Birk E, Schonfeld T.

Pediatr Pulmonol. 2017 Jan;52(1):77-83. doi: 10.1002/ppul.23508. Epub 2016 Jun 22.

PMID:
27333438
13.

Computer-generated real-time digital holography: first time use in clinical medical imaging.

Bruckheimer E, Rotschild C, Dagan T, Amir G, Kaufman A, Gelman S, Birk E.

Eur Heart J Cardiovasc Imaging. 2016 Aug;17(8):845-9. doi: 10.1093/ehjci/jew087. Epub 2016 Jun 9.

PMID:
27283456
14.

Holography for imaging in structural heart disease.

Bruckheimer E, Rotschild C.

EuroIntervention. 2016 May 17;12 Suppl X:X81-X84. doi: 10.4244/EIJV12SXA15.

15.

Amplatzer Vascular Plugs Versus Coils for Embolization of Pulmonary Arteriovenous Malformations in Patients with Hereditary Hemorrhagic Telangiectasia.

Tau N, Atar E, Mei-Zahav M, Bachar GN, Dagan T, Birk E, Bruckheimer E.

Cardiovasc Intervent Radiol. 2016 Aug;39(8):1110-4. doi: 10.1007/s00270-016-1357-7. Epub 2016 May 5.

PMID:
27150804
16.

Congenital Malformations Leading to Paradoxical Embolism.

Bruckheimer E.

Cardiol Clin. 2016 May;34(2):247-54. doi: 10.1016/j.ccl.2015.12.005. Epub 2016 Mar 10. Review.

PMID:
27150173
17.

Comparing Effective Doses During Image-Guided Core Needle Biopsies with Computed Tomography Versus C-Arm Cone Beam CT Using Adult and Pediatric Phantoms.

Ben-Shlomo A, Cohen D, Bruckheimer E, Bachar GN, Konstantinovsky R, Birk E, Atar E.

Cardiovasc Intervent Radiol. 2016 May;39(5):732-739. doi: 10.1007/s00270-015-1227-8. Epub 2015 Oct 22.

PMID:
26493824
18.

Cryotherapy ablation of parahisian accessory pathways in children.

Swissa M, Birk E, Dagan T, Fogelman M, Einbinder T, Bruckheimer E, Goldenberg I, Klempfner R, Kirsh JA, Fogelman R.

Heart Rhythm. 2015 May;12(5):917-25. doi: 10.1016/j.hrthm.2015.01.042. Epub 2015 Jan 29.

PMID:
25640635
19.

Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment.

Garralda E, Paz K, López-Casas PP, Jones S, Katz A, Kann LM, López-Rios F, Sarno F, Al-Shahrour F, Vasquez D, Bruckheimer E, Angiuoli SV, Calles A, Diaz LA, Velculescu VE, Valencia A, Sidransky D, Hidalgo M.

Clin Cancer Res. 2014 May 1;20(9):2476-84. doi: 10.1158/1078-0432.CCR-13-3047. Epub 2014 Mar 14.

20.

The Amplatzer Duct Occluder II Additional Sizes device for transcatheter PDA closure: initial experience.

Bruckheimer E, Godfrey M, Dagan T, Levinzon M, Amir G, Birk E.

Catheter Cardiovasc Interv. 2014 Jun 1;83(7):1097-101. doi: 10.1002/ccd.25445. Epub 2014 Mar 4.

PMID:
24532416
21.

Efficacy of bronchoscopic closure of a bronchopleural fistula with amplatzer devices: long-term follow-up.

Fruchter O, El Raouf BA, Abdel-Rahman N, Saute M, Bruckheimer E, Kramer MR.

Respiration. 2014;87(3):227-33. doi: 10.1159/000357074. Epub 2014 Jan 14.

22.

Preliminary experience using the transcatheter mitral valve leaflet repair procedure.

Perl L, Vaturi M, Assali A, Shapira Y, Bruckheimer E, Ben-Gal T, Vaknin-Assa H, Sagie A, Kornowski R.

Isr Med Assoc J. 2013 Oct;15(10):608-12.

23.

Percutaneous coronary intervention of the left main artery before MitraClip implantation.

Perl L, Vaturi M, Assali A, Shapira Y, Bruckheimer E, Vaknin-Assa H, Ben-Gal T, Sagie A, Kornowski R.

Cardiovasc Revasc Med. 2014 Jan;15(1):51-3. doi: 10.1016/j.carrev.2013.05.006. Epub 2013 Jul 5.

PMID:
23830743
24.

Percutaneous intraperitoneal catheters in neonates following open heart surgery.

Averbuch N, Birk E, Frenkel G, Gogia O, Shulman OM, Bruckheimer E, Nachum E, Amir G.

J Intensive Care Med. 2014 May-Jun;29(3):160-4. doi: 10.1177/0885066613482086. Epub 2013 Mar 25.

PMID:
23753237
25.

Transapical implantation of a Melody valve in a degenerated low-diameter prosthetic aortic valve.

Ben-Gal Y, Finkelstein A, Bruckheimer E, Banai S, Keren G, Kramer A, Uretzky G.

Circulation. 2013 Apr 23;127(16):e553-6. doi: 10.1161/CIRCULATIONAHA.112.127027. No abstract available.

PMID:
23609553
26.

Staged transcatheter treatment of portal hypoplasia and congenital portosystemic shunts in children.

Bruckheimer E, Dagan T, Atar E, Schwartz M, Kachko L, Superina R, Amir G, Shapiro R, Birk E.

Cardiovasc Intervent Radiol. 2013 Dec;36(6):1580-1585. doi: 10.1007/s00270-013-0581-7. Epub 2013 Feb 22.

PMID:
23435744
27.

Stenting Options for Coarctation of the Aorta.

Bruckheimer E, Pedra CAC.

Interv Cardiol Clin. 2013 Jan;2(1):115-129. doi: 10.1016/j.iccl.2012.08.002. Epub 2012 Dec 3. Review.

PMID:
28581978
28.

Direct innominate artery cannulation for antegrade cerebral perfusion in neonates undergoing arch reconstruction.

Amir G, Frenkel G, Shukrun G, Gogia O, Bachar O, Bruckheimer E, Katz J, Birk E.

Ann Thorac Surg. 2013 Mar;95(3):956-61. doi: 10.1016/j.athoracsur.2012.10.029. Epub 2012 Dec 20.

PMID:
23261118
29.

Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft.

Morelli MP, Calvo E, Ordoñez E, Wick MJ, Viqueira BR, Lopez-Casas PP, Bruckheimer E, Calles-Blanco A, Sidransky D, Hidalgo M.

J Clin Oncol. 2012 Feb 1;30(4):e45-8. doi: 10.1200/JCO.2011.36.9678. Epub 2011 Dec 19. No abstract available.

30.

A pilot clinical study of treatment guided by personalized tumorgrafts in patients with advanced cancer.

Hidalgo M, Bruckheimer E, Rajeshkumar NV, Garrido-Laguna I, De Oliveira E, Rubio-Viqueira B, Strawn S, Wick MJ, Martell J, Sidransky D.

Mol Cancer Ther. 2011 Aug;10(8):1311-6. doi: 10.1158/1535-7163.MCT-11-0233. Epub 2011 Jun 14.

31.

Endobronchial closure of bronchopleural fistulas with Amplatzer vascular plug.

Fruchter O, Bruckheimer E, Raviv Y, Rosengarten D, Saute M, Kramer MR.

Eur J Cardiothorac Surg. 2012 Jan;41(1):46-9. doi: 10.1016/j.ejcts.2011.02.080.

32.

Endobronchial closure of bronchopleural fistulae using amplatzer devices: our experience and literature review.

Fruchter O, Kramer MR, Dagan T, Raviv Y, Abdel-Rahman N, Saute M, Bruckheimer E.

Chest. 2011 Mar;139(3):682-687. doi: 10.1378/chest.10-1528. Review.

PMID:
21362655
33.

Diagnosis and percutaneous closure of a large coronary fistula.

Leitman M, Hirsch R, Rosenblatt S, Theodorovich N, Krakover R, Kornowski R, Bruckheimer E, Vered Z.

Echocardiography. 2011 Feb;28(2):248-52. doi: 10.1111/j.1540-8175.2010.01283.x. No abstract available.

PMID:
21276078
34.

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer.

Merritt WM, Kamat AA, Hwang JY, Bottsford-Miller J, Lu C, Lin YG, Coffey D, Spannuth WA, Nugent E, Han LY, Landen CN, Nick AM, Stone RL, Coffman K, Bruckheimer E, Broaddus RR, Gershenson DM, Coleman RL, Sood AK.

Cancer Biol Ther. 2010 Dec 15;10(12):1306-14. Epub 2010 Dec 15.

35.

Anomalous origin of the pulmonary artery from the aorta: early diagnosis and repair leading to immediate physiological correction.

Amir G, Frenkel G, Bruckheimer E, Dagan T, Katz J, Berant M, Vidne B, Birk E.

Cardiol Young. 2010 Dec;20(6):654-9. doi: 10.1017/S1047951110000892. Epub 2010 Aug 20.

PMID:
20723270
36.

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer.

Gökmen-Polar Y, Toroni RA, Hocevar BA, Badve S, Zhao Q, Shen C, Bruckheimer E, Kinch MS, Miller KD.

Breast Cancer Res Treat. 2011 Jun;127(2):375-84. doi: 10.1007/s10549-010-1004-y. Epub 2010 Jul 3.

PMID:
20602165
37.

Transcatheter closure of large congenital coronary-cameral fistulae with Amplatzer devices.

Bruckheimer E, Harris M, Kornowski R, Dagan T, Birk E.

Catheter Cardiovasc Interv. 2010 May 1;75(6):850-4. doi: 10.1002/ccd.22365.

PMID:
20146207
38.

Coarctation of the aorta treated with the Advanta V12 large diameter stent: acute results.

Bruckheimer E, Birk E, Santiago R, Dagan T, Esteves C, Pedra CA.

Catheter Cardiovasc Interv. 2010 Feb 15;75(3):402-6. doi: 10.1002/ccd.22280.

PMID:
19885914
39.

Stent graft closure of a high flow splenorenal shunt after liver transplantation.

Litvin S, Atar E, Knizhnik M, Bruckheimer E, Belenky A.

Diagn Interv Radiol. 2010 Dec;16(4):312-4. doi: 10.4261/1305-3825.DIR.2398-08.1. Epub 2009 Sep 25.

40.

Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.

Bruckheimer EM, Fazenbaker CA, Gallagher S, Mulgrew K, Fuhrmann S, Coffman KT, Walsh W, Ready S, Cook K, Damschroder M, Kinch M, Kiener PA, Woods R, Gao C, Dall'Acqua W, Wu H, Coats S.

Neoplasia. 2009 Jun;11(6):509-17, 2 p following 517.

41.

Covered Cheatham-Platinum stents for serial dilation of severe native aortic coarctation.

Bruckheimer E, Dagan T, Amir G, Birk E.

Catheter Cardiovasc Interv. 2009 Jul 1;74(1):117-23. doi: 10.1002/ccd.21923.

PMID:
19180664
42.

Enhancement in specific CD8+ T cell recognition of EphA2+ tumors in vitro and in vivo after treatment with ligand agonists.

Wesa AK, Herrem CJ, Mandic M, Taylor JL, Vasquez C, Kawabe M, Tatsumi T, Leibowitz MS, Finke JH, Bukowski RM, Bruckheimer E, Kinch MS, Storkus WJ.

J Immunol. 2008 Dec 1;181(11):7721-7.

43.

A vein entry indicator device for facilitating peripheral intravenous cannulation in children: a prospective, randomized, controlled trial.

Simhi E, Kachko L, Bruckheimer E, Katz J.

Anesth Analg. 2008 Nov;107(5):1531-5. doi: 10.1213/ane.0b013e318185cdab.

PMID:
18931210
44.

Use of Amplatzer device for endobronchial closure of bronchopleural fistulas.

Kramer MR, Peled N, Shitrit D, Atar E, Saute M, Shlomi D, Amital A, Bruckheimer E.

Chest. 2008 Jun;133(6):1481-1484. doi: 10.1378/chest.07-1961.

PMID:
18574292
45.

Pulmonary hypertension in an infant with achondroplasia.

Schiller O, Schwartz M, Bruckheimer E, Michowitz S, Garty BZ.

Pediatr Neurosurg. 2008;44(4):341-3. doi: 10.1159/000138374. Epub 2008 Jun 13.

PMID:
18552519
46.

TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.

Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N.

Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.

PMID:
18163430
47.

The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling.

Brantley-Sieders DM, Zhuang G, Hicks D, Fang WB, Hwang Y, Cates JM, Coffman K, Jackson D, Bruckheimer E, Muraoka-Cook RS, Chen J.

J Clin Invest. 2008 Jan;118(1):64-78.

48.

Selective targeting and potent control of tumor growth using an EphA2/CD3-Bispecific single-chain antibody construct.

Hammond SA, Lutterbuese R, Roff S, Lutterbuese P, Schlereth B, Bruckheimer E, Kinch MS, Coats S, Baeuerle PA, Kufer P, Kiener PA.

Cancer Res. 2007 Apr 15;67(8):3927-35.

49.
50.

Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.

Landen CN Jr, Lu C, Han LY, Coffman KT, Bruckheimer E, Halder J, Mangala LS, Merritt WM, Lin YG, Gao C, Schmandt R, Kamat AA, Li Y, Thaker P, Gershenson DM, Parikh NU, Gallick GE, Kinch MS, Sood AK.

J Natl Cancer Inst. 2006 Nov 1;98(21):1558-70.

PMID:
17077358

Supplemental Content

Loading ...
Support Center